Pharming Reveals Positive Trial Results for Leniolisib Study February 4, 2022 Auto Bot News 0 Pharming Group has announced positive results from the Phase II/III study of leniolisib for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS).